Search

everythinglearnresearchcommunity

for

Search:↓

New alopecia treatments aim for better results and fewer side effects.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Cetuximab can cause eyelash growth, which is rare but manageable.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Ginsenoside Rb1 from Panax ginseng helps mink hair grow by activating certain cell signals.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Natural products can help overcome cancer drug resistance.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Soy isoflavones can protect lung tissue from radiation damage.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.